A randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancer
一项随机、II期、生物标志物筛选研究，比较厄洛替尼单药治疗与厄洛替尼联合化疗一线治疗晚期非小细胞肺癌的疗效。
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2010.34.4929
Hirsch, Fred R; Kabbinavar, Fairooz; Eisen, Tim; Martins, Renato; Schnell, Fredrick M; Dziadziuszko, Rafal; Richardson, Katherine; Richardson, Frank; Wacker, Bret; Sternberg, David W; Rusk, Jason; Franklin, Wilbur A; Varella-Garcia, Marileila; Bunn, Paul A Jr; Camidge, D Ross
